Nicola Magrini, MD, has 25 years experience in drug evaluation, clinical trials, evidence synthesis and guideline development. He is a founding member of the Italian Cochrane Centre (1994), established the NHS CeVEAS, Centre for the evaluation of the effectiveness of Health care in Modena in 2000,, and is a member of the BMJ editorial board (2004-2007).

Magrini served at the WHO in Geneva as Secretary of the WHO Essential Medicines List (2014 to 2020). He was Director General of AIFA, the Italian Medicines Agency during Covid-19 pandemic from 2020 till Jan 2023.

Magrini is currently the Head of the Unit for Innovation, Evidence synthesis and Clinical research, IRCCS S.Orsola, Bologna and Co-director WHO Collaborating Centre for evidence synthesis and guideline development, Bologna, Italy.